We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-6.37%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$3.55B
AUM Growth
-$772M
Cap. Flow
-$469M
Cap. Flow %
-13.21%
Top 10 Hldgs %
58.31%
Holding
161
New
16
Increased
39
Reduced
56
Closed
15

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$126M
2
TCOM icon
Trip.com Group
TCOM
+$77.7M
3
ICVX
Icosavax, Inc. Common Stock
ICVX
+$26.7M
4
BTRS
BTRS Holdings Inc. Class 1 Common Stock
BTRS
+$23.5M
5
IDYA icon
IDEAYA Biosciences
IDYA
+$21.6M

Top Sells

Rank Stock Value
1
ALLY icon
Ally Financial
ALLY
+$177M
2
LPX icon
Louisiana-Pacific
LPX
+$118M
3
WAB icon
Wabtec
WAB
+$106M
4
AEO icon
American Eagle Outfitters
AEO
+$102M
5
YUMC icon
Yum China
YUMC
+$52M

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Industrials 21.06%
3 Consumer Discretionary 20.58%
4 Healthcare 13.81%
5 Materials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
76
Wave Life Sciences
WVE
$1.19B
$3.8M 0.11%
776,121
+569,737
+276% +$3.45M
TKNO icon
77
Alpha Teknova
TKNO
$348M
$3.73M 0.11%
150,000
– –
MDLA
78
DELISTED
Medallia, Inc.
MDLA
$3.7M 0.1%
109,307
-796,677
-88% -$26.6M
HOWL icon
79
Werewolf Therapeutics
HOWL
$19.3M
$3.66M 0.1%
213,381
+6,466
+3% +$110K
INBX
80
DELISTED
Inhibrx, Inc. Common Stock
INBX
$3.45M 0.1%
103,583
-51,818
-33% -$1.58M
ABSI icon
81
Absci
ABSI
$1.53B
$3.34M 0.09%
+287,560
New +$5.58M
MASS icon
82
908 Devices
MASS
$363M
$3.28M 0.09%
100,961
+51,801
+105% +$1.76M
ADI icon
83
Analog Devices
ADI
$188B
$3.04M 0.09%
18,145
-12,139
-40% -$2.04M
PYPL icon
84
PayPal
PYPL
$50.1B
$3M 0.08%
11,543
-1,056
-8% -$300K
X
85
DELISTED
US Steel
X
$3M 0.08%
136,600
+64,664
+90% +$1.62M
BPMC
86
DELISTED
Blueprint Medicines
BPMC
$2.79M 0.08%
27,121
– –
ADPT icon
87
Adaptive Biotechnologies
ADPT
$4.12B
$2.78M 0.08%
81,894
+23,004
+39% +$832K
OVID icon
88
Ovid Therapeutics
OVID
$476M
$2.58M 0.07%
766,901
+370,031
+93% +$1.35M
CVNA icon
89
Carvana
CVNA
$79.7B
$2.51M 0.07%
41,580
-82,270
-66% -$5.47M
BCEL
90
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2.48M 0.07%
398,541
+81,524
+26% +$543K
ORTX
91
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2.48M 0.07%
107,832
+32,621
+43% +$970K
ALKS icon
92
Alkermes
ALKS
$8.25B
$2.47M 0.07%
80,185
-101,901
-56% -$2.88M
XLRN
93
DELISTED
Acceleron Pharma
XLRN
$2.39M 0.07%
13,872
– –
DNTH icon
94
Dianthus Therapeutics
DNTH
$6.08B
$2.33M 0.07%
20,044
– –
RNAM
95
DELISTED
Avidity Biosciences
RNAM
$2.33M 0.07%
94,496
+79,496
+530% +$1.73M
ORCL icon
96
Oracle
ORCL
$432B
$2.2M 0.06%
25,213
-571
-2% -$50.4K
YMM icon
97
Full Truck Alliance
YMM
$10B
$2.18M 0.06%
+141,924
New +$2.09M
RCUS icon
98
Arcus Biosciences
RCUS
$3.64B
$2.15M 0.06%
61,780
-13,510
-18% -$420K
BNTX icon
99
BioNTech
BNTX
$23.4B
$2.04M 0.06%
7,492
-54,567
-88% -$17.3M
SGMO
100
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.97M 0.06%
218,336
– –
2 3
4
5 6

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Platinum Investment Management held 161 positions worth $3.55B, down 18% from $4.32B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Platinum Investment Management withdrew a net $469M in Q3 2021, closing 15 positions and reducing 56 holdings. Its most notable exit was Wabtec, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Platinum Investment Management opened a new position in Icosavax, Inc. Common Stock worth $23.3M.

  • Platinum Investment Management's largest Q3 2021 buy was Icosavax, Inc. Common Stock: 786,575 shares worth $23.3M.
  • Platinum Investment Management added most to Alibaba in Q3 2021, an estimated $126M increase.
  • Platinum Investment Management's biggest Q3 2021 reduction was Ally Financial, cutting an estimated $177M.
  • Platinum Investment Management fully exited Wabtec in Q3 2021, selling an estimated $106M.
  • Platinum Investment Management's ten largest holdings make up 58% of its $3.55B portfolio in Q3 2021.
  • Platinum Investment Management opened 16 new positions and closed 15 in Q3 2021.
  • Platinum Investment Management's portfolio value fell 18% quarter-over-quarter to $3.55B.

Based on Platinum Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.